Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a

Laura A Grutters1, Imke Christiaans2

  • 1Department of Genetics, University of Groningen, University Medical Center Groningen, Hanzeplein 1, P.O. Box 30.001, Groningen, 9700 RB, The Netherlands.

Familial Cancer
|January 6, 2024
PubMed

Insights

Cascade genetic counseling and testing for inherited cardiovascular diseases show limited long-term uptake among at-risk relatives. Further research into barriers, including health system issues, is needed to improve participation rates.

Area of Science:

  • Cardiovascular Genetics
  • Medical Genetics
  • Public Health

Background:

  • Inherited cardiovascular diseases (ICDs) affect 1-2% of the global population.
  • These include familial hypercholesterolemia, cardiomyopathies, and arrhythmia syndromes.
  • Cascade genetic counseling and testing are valuable due to available preventive measures and treatments.

Purpose of the Study:

  • To review the uptake of cascade genetic counseling and testing in ICDs.
  • To identify barriers impeding at-risk relatives from seeking genetic counseling and testing.
  • To propose future research directions for optimizing uptake.

Main Methods:

  • Review of academic literature on cascade genetic counseling and testing in ICDs.
  • Analysis of factors influencing uptake rates among at-risk relatives.
  • Identification of knowledge, attitudinal, social, and practical barriers.

Main Results:

  • Family-mediated cascade genetic counseling leads to ~40% uptake one year post-proband identification, with long-term uptake remaining incomplete.
  • Previous interventions focusing on information dissemination have had minimal impact on uptake.
  • Significant uptake improvement was observed in familial hypercholesterolemia with reduced health-system barriers.

Conclusions:

  • Current cascade genetic counseling and testing strategies have suboptimal long-term uptake.
  • Understanding the complex interplay of barriers in decision-making is crucial.
  • Further research on health-system-related barriers is essential for developing effective interventions to optimize genetic counseling and testing uptake.

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Pedigree Analysis01:35

Pedigree Analysis

Overview
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...